The role of PPARγ-mediated signalling in skin biology and pathology: New targets and opportunities for clinical dermatology

Experimental Dermatology

Volumn 24, Issue 4, 2015, Pages 245-251

  Ramot, Yuval ^a   Mastrofrancesco, Arianna ^b   Camera, Emanuela ^b   Desreumaux, Pierre ^c   Paus, Ralf ^d,e   Picardo, Mauro ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^c UNIV LILLE   (France)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e INST OF REPRO MED OF THE UNIV   (Germany)

Author keywords

Hair; Inflammation; Peroxisome proliferator activated receptors; Skin; Treatment

Indexed keywords

LIGAND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SKIN LIPID; 2,4 THIAZOLIDINEDIONE DERIVATIVE; AUTACOID;

ACNE; ACNE VULGARIS; ALOPECIA; APOPTOSIS; ATOPIC DERMATITIS; CONTACT DERMATITIS; CUTANEOUS PARAMETERS; DERMATITIS; FUNCTIONS OF THE SKIN AND ITS APPENDAGES; HAIR GROWTH; HUMAN; KERATINOCYTE; LIPID METABOLISM; NONHUMAN; PSORIASIS; REVIEW; SKIN CANCER; SKIN DISEASE; AGONISTS; ANIMAL; DRUG EFFECTS; HAIR; HAIR DISEASES; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SKIN; SKIN DISEASES; SKIN NEOPLASMS;

ANIMALS; HAIR; HAIR DISEASES; HUMANS; INFLAMMATION MEDIATORS; LIGANDS; PPAR GAMMA; SIGNAL TRANSDUCTION; SKIN; SKIN AGING; SKIN DISEASES; SKIN NEOPLASMS; SKIN PHYSIOLOGICAL PHENOMENA; THIAZOLIDINEDIONES;

EID: 84925965583     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12647     Document Type: Review

References (158)

1. Sertznig P, Reichrath J. Dermatoendocrinol 2011: 3: 130-135.
2. Sertznig P, Seifert M, Tilgen W et al. Am J Clin Dermatol 2008: 9: 15-31.
3. Ricote M, Glass C K. Biochim Biophys Acta 2007: 1771: 926-935.
4. Zoete V, Grosdidier A, Michielin O. Biochim Biophys Acta 2007: 1771: 915-925.
5. Jiang C, Ting A T, Seed B. Nature 1998: 391: 82-86.
6. Henson P. Proc Natl Acad Sci USA 2003: 100: 6295-6296.
7. Marx N, Kehrle B, Kohlhammer K et al. Circ Res 2002: 90: 703-710.
8. Sugiyama H, Nonaka T, Kishimoto T et al. Eur J Immunol 2000: 30: 3363-3370.
9. Szeles L, Torocsik D, Nagy L. Biochim Biophys Acta 2007: 1771: 1014-1030.
10. Narala V R, Subramani P A, Narasimha V R et al. Int Immunopharmacol 2014: 23: 283-287.
11. Sahebkar A, Chew G T, Watts G F. Expert Opin Pharmacother 2014: 15: 493-503.
12. Mansour M. Prog Mol Biol Transl Sci 2014: 121: 217-266.
13. Bishop-Bailey D, Wray J. Prostaglandins Other Lipid Mediat 2003: 71: 1-22.
14. Benoit G, Cooney A, Giguere V et al. Pharmacol Rev 2006: 58: 798-836.
15. Coleman J D, Prabhu K S, Thompson J T et al. Free Radic Biol Med 2007: 42: 1155-1164.
16. Schupp M, Lazar M A. J Biol Chem 2010: 285: 40409-40415.
17. Straus D S, Glass C K. Trends Immunol 2007: 28: 551-558.
18. Varga T, Czimmerer Z, Nagy L. Biochim Biophys Acta 1812: 2011: 1007-1022.
19. Schmidt M V, Brune B, von Knethen A. ScientificWorldJournal 2010: 10: 2181-2197.
20. Ahmadian M, Suh J M, Hah N et al. Nat Med 2013: 19: 557-566.
21. Jia Z, Sun Y, Yang G et al. PPAR Res 2014: 2014: 818530.
22. Kung J, Henry R R. Expert Opin Drug Saf 2012: 11: 565-579.
23. Nissen S E, Wolski K. N Engl J Med 2007: 356: 2457-2471.
24. Higgins L S, Depaoli A M. Am J Clin Nutr 2010: 91: 267S-272S.
25. Assefa Z, Van Laethem A, Garmyn M et al. Biochim Biophys Acta 2005: 1755: 90-106.
26. Pirat C, Farce A, Lebegue N et al. J Med Chem 2012: 55: 4027-4061.
27. Sears D D, Hsiao A, Ofrecio J M et al. Biochem Biophys Res Commun 2007: 364: 515-521.
28. Billoni N, Buan B, Gautier B et al. Acta Derm Venereol 2000: 80: 329-334.
29. Schmuth M, Moosbrugger-Martinz V, Blunder S et al. Biochim Biophys Acta 1841: 2014: 463-473.
30. Westergaard M, Henningsen J, Svendsen M L et al. J Invest Dermatol 2001: 116: 702-712.
31. Icre G, Wahli W, Michalik L. J Investig Dermatol Symp Proc 2006: 11: 30-35.
32. Alestas T, Ganceviciene R, Fimmel S et al. J Mol Med 2006: 84: 75-87.
33. Inoue T, Miki Y, Kakuo S et al. J Endocrinol 2014: 222: 301-312.
34. Yessoufou A, Wahli W. Swiss Med Wkly 2010: 140: w13071.
35. Klein J, Permana P A, Owecki M et al. Exp Dermatol 2007: 16: 45-70.
36. Nehrenheim K, Meyer I, Brenden H et al. Exp Dermatol 2013: 22: 638-643.
37. Lemberger T, Braissant O, Juge-Aubry C et al. Ann N Y Acad Sci 1996: 804: 231-251.
38. Michalik L, Desvergne B, Tan N S et al. J Cell Biol 2001: 154: 799-814.
39. Adachi Y, Hatano Y, Sakai T et al. Exp Dermatol 2013: 22: 606-608.
40. Demerjian M, Man M Q, Choi E H et al. Exp Dermatol 2006: 15: 154-160.
41. Mao-Qiang M, Fowler A J, Schmuth M et al. J Invest Dermatol 2004: 123: 305-312.
42. Dubrac S, Stoitzner P, Pirkebner D et al. J Immunol 2007: 178: 4362-4372.
43. Dubrac S, Schmuth M. Dermatoendocrinol 2011: 3: 23-26.
44. Tyagi S, Gupta P, Saini A S et al. J Adv Pharm Technol Res 2011: 2: 236-240.
45. Fluhr J W, Man M Q, Hachem J P et al. J Invest Dermatol 2009: 129: 365-374.
46. Behshad R, Cooper K D, Korman N J. Arch Dermatol 2008: 144: 84-88.
47. Boguniewicz M, Leung D Y. Immunol Rev 2011: 242: 233-246.
48. Dahten A, Koch C, Ernst D et al. J Invest Dermatol 2008: 128: 2211-2218.
49. Jung K, Tanaka A, Fujita H et al. J Allergy Clin Immunol 2011: 127: 420-429, e421-426.
50. Tachibana M, Wada K, Katayama K et al. Allergy 2008: 63: 1136-1147.
51. Westergaard M, Henningsen J, Johansen C et al. J Invest Dermatol 2003: 121: 1104-1117.
52. Bongartz T, Coras B, Vogt T et al. Rheumatology (Oxford) 2005: 44: 126-129.
53. Mittal R, Malhotra S, Pandhi P et al. Arch Dermatol 2009: 145: 387-393.
54. Robertshaw H, Friedmann P S. Br J Dermatol 2005: 152: 189-191.
55. Shafiq N, Malhotra S, Pandhi P et al. Int J Dermatol 2005: 44: 328-333.
56. Ellis C N, Barker J N, Haig A E et al. Am J Clin Dermatol 2007: 8: 93-102.
57. Kuenzli S, Saurat J H. Dermatology 2003: 206: 252-256.
58. Mastrofrancesco A, Kovacs D, Sarra M et al. J Invest Dermatol 2014: 134: 1001-1011.
59. Shlyankevich J, Mehta N N, Krueger J G et al. Am J Med 2014: 127: 1148-1153.
60. Toth B I, Olah A, Szollosi A G et al. Pflugers Arch 2011: 461: 593-606.
61. Downie M M, Sanders D A, Maier L M et al. Br J Dermatol 2004: 151: 766-775.
62. Rosenfield R L, Kentsis A, Deplewski D et al. J Invest Dermatol 1999: 112: 226-232.
63. Trivedi N R, Cong Z, Nelson A M et al. J Invest Dermatol 2006: 126: 2002-2009.
64. Zhang Q, Seltmann H, Zouboulis C C et al. J Invest Dermatol 2006: 126: 42-48.
65. Rosenfield R L, Deplewski D, Kentsis A et al. Dermatology 1998: 196: 43-46.
66. Hong I, Lee M H, Na T Y et al. J Invest Dermatol 2008: 128: 1266-1272.
67. Nesto R W, Bell D, Bonow R O et al. Diabetes Care 2004: 27: 256-263.
68. Soccio R E, Chen E R, Lazar M A. Cell Metab 2014: 20: 573-591.
69. Berria R, Glass L, Mahankali A et al. Clin Pharmacol Ther 2007: 82: 275-281.
70. Colhoun H M, Livingstone S J, Looker H C et al. Diabetologia 2012: 55: 2929-2937.
71. Ferwana M, Firwana B, Hasan R et al. Diabet Med 2013: 30: 1026-1032.
72. Colmers I N, Bowker S L, Johnson J A. Diabetes Metab 2012: 38: 475-484.
73. Han A, Chien A L, Kang S. Dermatol Clin 2014: 32: 291-299, vii.
74. Chung J H, Seo A Y, Chung S W et al. Ageing Res Rev 2008: 7: 126-136.
75. Lee Y H, Lee N H, Bhattarai G et al. Cell Biochem Funct 2010: 28: 490-496.
76. Yoshizaki N, Fujii T, Masaki H et al. Exp Dermatol 2014: 23(Suppl. 1): 18-22.
77. Kim J K, Mun S, Kim M S et al. Exp Dermatol 2012: 21: 211-216.
78. Blanquart C, Barbier O, Fruchart J C et al. J Steroid Biochem Mol Biol 2003: 85: 267-273.
79. Briganti S, Flori E, Mastrofrancesco A et al. Exp Dermatol 2013: 22: 41-47.
80. Okuno Y, Matsuda M, Miyata Y et al. Endocr J 2010: 57: 303-309.
81. Flori E, Mastrofrancesco A, Kovacs D et al. Pigment Cell Melanoma Res 2011: 24: 618-630.
82. Wei J, Bhattacharyya S, Varga J. Curr Opin Rheumatol 2010: 22: 671-676.
83. Burgess H A, Daugherty L E, Thatcher T H et al. Am J Physiol Lung Cell Mol Physiol 2005: 288: L1146-L1153.
84. Ghosh A K, Bhattacharyya S, Lakos G et al. Arthritis Rheum 2004: 50: 1305-1318.
85. Shi-wen X, Eastwood M, Stratton R J et al. Rheumatology (Oxford) 2010: 49: 259-263.
86. Wu M, Melichian D S, Chang E et al. Am J Pathol 2009: 174: 519-533.
87. Yang L, Chan C C, Kwon O S et al. Am J Physiol Gastrointest Liver Physiol 2006: 291: G902-G911.
88. Zheng F, Fornoni A, Elliot S J et al. Am J Physiol Renal Physiol 2002: 282: F639-F648.
89. Zhang X, Lin S, Funk W E et al. Occup Environ Med 2013: 70: 743-749.
90. Grommes C, Landreth G E, Heneka M T. Lancet Oncol 2004: 5: 419-429.
91. Koeffler H P. Clin Cancer Res 2003: 9: 1-9.
92. Elnemr A, Ohta T, Iwata K et al. Int J Oncol 2000: 17: 1157-1164.
93. Gupta R A, Brockman J A, Sarraf P et al. J Biol Chem 2001: 276: 29681-29687.
94. Koga H, Sakisaka S, Harada M et al. Hepatology 2001: 33: 1087-1097.
95. Sarraf P, Mueller E, Jones D et al. Nat Med 1998: 4: 1046-1052.
96. Tontonoz P, Singer S, Forman B M et al. Proc Natl Acad Sci USA 1997: 94: 237-241.
97. Wei S, Lin L F, Yang C C et al. Mol Pharmacol 2007: 72: 725-733.
98. Palakurthi S S, Aktas H, Grubissich L M et al. Cancer Res 2001: 61: 6213-6218.
99. Bae M A, Song B J. Mol Pharmacol 2003: 63: 401-408.
100. Patel L, Pass I, Coxon P et al. Curr Biol 2001: 11: 764-768.
101. Shiau C W, Yang C C, Kulp S K et al. Cancer Res 2005: 65: 1561-1569.
102. Glass C K, Saijo K. Nat Rev Immunol 2010: 10: 365-376.
103. Kim D, Garza L A. Exp Dermatol 2015: 24: 14-15.
104. Maresca V, Flori E, Camera E et al. Pigment Cell Melanoma Res 2013: 26: 113-127.
105. Eastham L L, Mills C N, Niles R M. Pharm Res 2008: 25: 1327-1333.
106. Mossner R, Schulz U, Kruger U et al. J Invest Dermatol 2002: 119: 576-582.
107. Grabacka M, Placha W, Plonka P M et al. Arch Dermatol Res 2004: 296: 54-58.
108. Grabacka M, Plonka P M, Urbanska K et al. Clin Cancer Res 2006: 12: 3028-3036.
109. Liu Y, Meng Y, Li H et al. Med Oncol 2006: 23: 393-402.
110. Sertznig P, Dunlop T, Seifert M et al. Anticancer Res 2009: 29: 3647-3658.
111. Fracasso P M, Picus J, Wildi J D et al. Cancer Chemother Pharmacol 2009: 63: 451-458.
112. Meyer S, Vogt T, Landthaler M et al. PPAR Res 2009: 2009: 848645.
113. Lien W H, Polak L, Lin M et al. Nat Cell Biol 2014: 16: 179-190.
114. Nguyen H, Rendl M, Fuchs E. Cell 2006: 127: 171-183.
115. Karnik P, Tekeste Z, McCormick T S et al. J Invest Dermatol 2009: 129: 1243-1257.
116. Harries M J, Paus R. J Invest Dermatol 2009: 129: 1066-1070.
117. Ramot Y, Mastrofrancesco A, Herczeg-Lisztes E et al. J Invest Dermatol 2014: 134: 1128-1131.
118. Harries M J, Meyer K, Chaudhry I et al. J Pathol 2013: 231: 236-247.
119. Choi J M, Bothwell A L. Mol Cells 2012: 33: 217-222.
120. Mirmirani P, Karnik P. Arch Dermatol 2009: 145: 1363-1366.
121. Dozsa A, Dezso B, Toth B I et al. J Invest Dermatol 2014: 134: 910-920.
122. Poiraud C, Quereux G, Knol A C et al. Exp Dermatol 2012: 21: 347-351.
123. Youssef J, Badr M. ScientificWorldJournal 2002: 2: 1491-1500.
124. Wei J, Zhu H, Komura K et al. Ann Rheum Dis 2014: 73: 446-454.
125. El-Jamal N, Dubuquoy L, Auwerx J et al. Exp Dermatol 2013: 22: 137-140.
126. Sheu M Y, Fowler A J, Kao J et al. J Invest Dermatol 2002: 118: 94-101.
127. Agrawal R, Jain P, Dikshit S N. Mini Rev Med Chem 2012: 12: 87-97.
128. Yew T, Toh S A, Millar J S. Recent Pat Cardiovasc Drug Discov 2012: 7: 33-41.
129. Nakamura M T, Yudell B E, Loor J J. Prog Lipid Res 2014: 53: 124-144.
130. Puligheddu M, Pillolla G, Melis M et al. PLoS ONE 2013: 8: e64541.
131. Yousefi B, Jadidi-Niaragh F, Azizi G et al. Mod Rheumatol 2014: 24: 225-235.
132. Yousefipour Z, Newaz M. Acta Pharmacol Sin 2014: 35: 476-482.
133. Matin A, Doddareddy M R, Gavande N et al. Bioorg Med Chem 2013: 21: 766-778.
134. Lo Verme J, Fu J, Astarita G et al. Mol Pharmacol 2005: 67: 15-19.
135. Rahn E J, Hohmann A G. Neurotherapeutics 2009: 6: 713-737.
136. Sozmen M, Devrim A K, Tunca R et al. J Vet Sci 2014: 15: 51-60.
137. Masi L N, Rodrigues A C, Curi R. Curr Opin Clin Nutr Metab Care 2013: 16: 418-424.
138. Ma J J, Monsivais D, Dyson M T et al. Horm Cancer 2013: 4: 358-370.
139. Kurtz M, Capobianco E, Martinez N et al. Life Sci 2010: 86: 781-790.
140. Chawla A, Lee C H, Barak Y et al. Proc Natl Acad Sci USA 2003: 100: 1268-1273.
141. Chiang M C, Cheng Y C, Chen H M et al. Mitochondrion 2014: 14: 7-17.
142. Yamada H, Oshiro E, Kikuchi S et al. J Lipid Res 2014: 55: 895-904.
143. Lamounier R N, Coimbra C N, White P et al. Diabetol Metab Syndr 2013: 5: 1.
144. Vangaveti V N, Shashidhar V M, Rush C et al. Lipids 2014: 49: 181-192.
145. Yan Y, Furumura M, Numata S et al. Exp Dermatol 2015: 24: 62-65.
146. Chen K, Li J, Wang J et al. PPAR Res 2014: 2014: 215631.
147. Huang C D, Hsiung T C, Ho S C et al. Biomed J 2014: 37: 191-198.
148. Wright M B, Bortolini M, Tadayyon M et al. Mol Endocrinol 2014: 28: 1756-1768. me20131427.
149. Doshi L S, Brahma M K, Bahirat U A et al. Expert Opin Investig Drugs 2010: 19: 489-512.
150. Rivier M, Safonova I, Lebrun P et al. J Invest Dermatol 1998: 111: 1116-1121.
151. Jones D C, Ding X, Daynes R A. J Biol Chem 2002: 277: 6838-6845.
152. Sugiyama H, Nonaka T, Kishimoto T et al. Eur J Immunol 2000: 30: 3363-3370.
153. Chen W, Yang C C, Sheu H M et al. J Invest Dermatol 2003: 121: 441-447.
154. Bhagavathula N, Nerusu K C, Reddy M et al. J Pharmacol Exp Ther 2005: 315: 996-1004.
155. Pershadsingh H A, Sproul J A, Benjamin E et al. Arch Dermatol 1998: 134: 1304-1305.
156. Ellis C N, Varani J, Fisher G J et al. Arch Dermatol 2000: 136: 609-616.
157. Brauchli Y B, Jick S S, Curtin F et al. J Am Acad Dermatol 2008: 58: 421-429.
158. Hack K, Reilly L, Palmer C et al. PLoS ONE 2012: 7: e37097.